MARC record from Internet Archive

LEADER: 09691cam 2200877 a 4500
001 ocm38289146
003 OCoLC
005 20200520020346.0
008 980121s1998 dcuab b 001 0 eng
010 $a 98002732
040 $aDLC$beng$cDLC$dLVB$dNLM$dMUQ$dBAKER$dBTCTA$dYDXCP$dZWZ$dGEBAY$dCNCGM$dTULIB$dOCLCO$dOCLCF$dEUX$dOCLCQ$dDEBBG$dOCLCQ$dOCLCO$dOCLCA$dSNN$dOCLCQ$dOCLCA$dAZU
016 7 $a9811831$2DNLM
019 $a41327451$a491999799$a934925125
020 $a1555811299$q(hardcover)
020 $a9781555811297$q(hardcover)
035 $a(OCoLC)38289146$z(OCoLC)41327451$z(OCoLC)491999799$z(OCoLC)934925125
050 00 $aQR201.E82$bE83 1998
060 00 $a1998 H-101
060 10 $aWC 290$bE74 1998
082 00 $a616/.01442$221
082 04 $a579.342
245 00 $aEscherichia coli O157:H7 and other shiga toxin-producing E. coli strains /$ceditors, James B. Kaper, Alison D. O'Brien.
260 $aWashington, DC :$bASM Press,$c℗♭1998.
300 $axxii, 465 pages :$billustrations (some color), maps ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $aBased on a symposium and workshop held in Baltimore, Maryland, 22-26 June 1997.
504 $aIncludes bibliographical references and index.
505 0 $a1. Shiga Toxin-Producing Escherichia coli: Yesterday, Today, and Tomorrow / Alison D. O'Brien and James B. Kaper -- I. Epidemiology of STEC in Humans. 2. Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Humans in the United States / Patricia M. Griffin. 3. Shiga Toxin-Producing Escherichia coli Infections in Canada / John S. Spika, Rasik Khakhria and Pascal Michel. 4. Epidemiology of Shiga Toxin-Producing Escherichia coli in South America / Eduardo L. Lopez, Maria Marta Contrini and Maria Fabiana De Rosa. 5. Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Continental Europe / Alfredo Caprioli and Alberto Eugenio Tozzi. 6. Shiga Toxin (Verocytotoxin)-Producing Escherichia coli in the United Kingdom / Henry R. Smith, Bernard Rowe and Goutam K. Adak. 7. An Outbreak of Escherichia coli O157:H7 in Central Scotland / Syed Ahmed and Martin Donaghy. 8. Shiga Toxin-Producing Escherichia coli in Australia / Roy M. Robins-Browne, Elizabeth Elliott and Patricia Desmarchelier. 9. Recent Outbreaks of Infections Caused by Escherichia coli O157:H7 in Japan / Hideshi Michino, Kazuhiro Araki and Shunsaku Minami -- II. Stec in the Food Chain. 10. Ecology of Escherichia coli O157:H7 in Cattle and Impact of Management Practices / Dale D. Hancock, Thomas E. Besser and Daniel H. Rice. 11. Microbiology of Shiga Toxin-Producing Escherichia coli in Foods / Jianghong Meng and Michael P. Doyle. 12. Food Safety in the United States / Jill Hollingsworth and Bruce Kaplan -- III. Pathogenic Mechanisms: Bacterial Factors. 13. Structure, Biology, and Relative Toxicity of Shiga Toxin Family Members for Cells and Animals / Angela R. Melton-Celsa and Alison D. O'Brien. 14. Shiga Toxin (Verotoxin) Binding to Its Receptor Glycolipid / C.A. Lingwood, M. Mylvaganam and S. Arab. 15. Shiga Toxin Interaction with Intestinal Epithelial Cells / David W.K. Acheson, Lisa L. Lincicome and Mary S. Jacewicz. 16. Intimin-Mediated Adherence of Shiga Toxin-Producing Escherichia coli and Attaching-and-Effacing Pathogens / James B. Kaper, Lisa J. Gansheroff and Marian R. Wachtel. 17. Intimin-Independent Adherence Mechanisms of Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains / Phillip I. Tarr and Sima S. Bilge. 18. Attaching-and-Effacing Intestinal Histopathology and the Locus of Enterocyte Effacement / James B. Kaper, Simon Elliott and Vanessa Sperandio. 19. Plasmid-Encoded Determinants of Escherichia coli O157:H7 / Helge Karch, Herbert Schmidt and Wemer Brunder. 20. Evolution of Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains / Thomas S. Whittam -- IV. Pathogenic Mechanisms: Host Response and Animal Models. 21. Epithelial Cell Responses to Shiga Toxin-Producing Escherichia coli Infection / Arif Ismaili, Dana J. Philpott and Derek M. McKay. 22. Cytokine Response to Shiga Toxins / Vernon L. Tesh. 23. Human Immune Response and Immunity to Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infection / Mohamed A. Karmah. 24. Overview of Animal Models / Rodney A. Moxley and David H. Francis. 25. Bovine Infection with Shiga Toxin-Producing Escherichia coli / Evelyn A. Dean-Nystrom, Brad T. Bosworth and Harley W. Moon. 26. Canine Model of Hemolytic-Uremic Syndrome / Brad W. Fenwick and Laine A. Cowan. 27. Interleukin-1 Receptor Antagonist Protects against Tissue Injury in an Animal Model of Hemorrhagic Colitis / Peter D. Bloom, Robert G. Russell and Edgar C. Boedeker -- V. Pathogenesis of Hemolytic-Uremic Syndrome. 28. Pathophysiology of Hemolytic-Uremic Syndrome / Leo Monnens, C.O. Savage and C.M. Taylor. 29. Hematology of Hemolytic-Uremic Syndrome / Peter Rose and Ian Chant. 30. Interaction of Shiga Toxins with Endothelial Cells / Tom G. Obrig. 31. Novel Role of Basic Fibroblast Growth Factor in the Pathogenesis of Classic Hemolytic-Uremic Syndrome / Patricio E. Ray, Angel Onorio and Jorge Sgromo. 32. Shiga Toxin (Verotoxin) Toxicity in Human Cerebral Endothelial Cells / James S. Hutchison, Danica Stanimirovic and Anthony Shapiro -- VI. Diagnosis and Treatment of STEC Infections. 33. Overview of Detection and Subtyping Methods / Nancy A. Strockbine, Joy G. Wells and Cheryl A. Bopp. 34. Treatment of Disease Due to Shiga Toxin-Producing Escherichia coli: Infectious Disease Management / Marguerite A. Neill. 35. Principles of the Treatment of Shiga Toxin-Associated Hemolytic-Uremic Syndrome: Pay Meticulous Attention to Detail, and Do No Harm / Kevin E.C. Meyers, Seth L. Schulman and Bernard S. Kaplan. 36. Clinical Trials of Synsorb-Pk in Preventing Hemolytic-Uremic Syndrome / Glen D. Armstrong, Peter N. McLaine and Peter C. Rowe. 37. Early Use of Fosfomycin for Shiga Toxin-Producing Escherichia coli O157 Infection Reduces the Risk of Hemolytic-Uremic Syndrome / Tae Takeda, Ken-ichi Yoshino and Hiroshi Uchida. 38. Vero Cell Neutralization and Mouse Protective Efficacy of Humanized Monocional Antibodies against Escherichia coli Toxins Stx1 and Stx2 / Ana C. Edwards, Angela R. Melton-Celsa and Kathy Arbuthnott. 39. Shiga Toxin-Producing Escherichia coli Infections: Challenges and Opportunities / Phillip I. Tarr -- VII. Vaccines Against STEC. 40. Immunoprophylaxis of Shiga Toxin-Producing Escherichia coli Infection and Disease: Strengths and Weaknesses of Various Strategies / Myron M. Levine. 41. Toxoid-Based Active and Passive Immunization To Prevent and/or Modulate Hemolytic-Uremic Syndrome Due to Shiga Toxin-Producing Escherichia coli / Gerald T. Keusch, David W.K. Acheson and Colin Marchant. 42. Synthesis and Immunologic Properties of O-Specific Polysaccharide-Protein Conjugate Vaccines for Prevention and Treatment of Infections with Escherichia coli O157 and Other Causes of Hemolytic-Uremic Syndrome / Edward Konadu, James C. Parke, Jr. and Arthur Donohue-Rolfe. 43. Live, Oral Attenuated Vaccine Vectors for Prevention of Shiga Toxin-Producing Escherichia coli Infection / Joan R. Butterton and Stephen B. Calderwood. 44. Vaccines and Shiga Toxin-Producing Escherichia coli in Animals / C.L. Cyles. 45. Public Health Perspective on Immunoprophylactic Strategies for Escherichia coli O157:H7: Who or What Would We Immunize? / Robert V. Tauxe.
508 $aBased on a symposium and workshop held in Baltimore, Maryland, 22-26 June 1997.
650 0 $aEscherichia coli infections.
650 0 $aVerocytotoxins.
650 0 $aHemolytic-uremic syndrome.
650 12 $aEscherichia coli Infections.
650 22 $aBacterial Toxins.
650 22 $aCytotoxins.
650 22 $aHemolytic-Uremic Syndrome.
650 6 $aColibacillose$xCongre s.
650 6 $aVe rocytotoxines$xCongre s.
650 6 $aSyndrome he molytique et ure mique$xCongre s.
650 7 $aInfections a Escherichia coli$xCongre s comme sujet.$2fmesh
650 7 $aSyndrome he molytique et ure mique$xCongre s comme sujet.$2fmesh
650 7 $aShiga toxine 1$xCongre s comme sujet.$2fmesh
650 7 $aEscherichia coli infections.$2fast$0(OCoLC)fst00915174
650 7 $aHemolytic-uremic syndrome.$2fast$0(OCoLC)fst00955077
650 7 $aVerocytotoxins.$2fast$0(OCoLC)fst01165424
650 7 $aHa molytisch-ura misches Syndrom$2gnd
650 7 $aInfektion$2gnd
650 7 $aVergiftung$2gnd
650 7 $aVerotoxine$2gnd
650 7 $aEscherichia coli$xCongre s.$2ram
650 7 $aKongress$2gnd
650 07 $aInfektion.$2swd
650 07 $aKongress.$2swd
650 07 $aVerotoxine.$2swd
650 07 $aVergiftung.$2swd
650 07 $aHa molytisch-ura misches Syndrom.$2swd
655 4 $aEHEL.
655 4 $aKongress$zBaltimore (Md.)$y1997.
700 1 $aKaper, James B.
700 1 $aO'Brien, Alison D.
856 41 $3Table of contents$uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008378493&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
938 $aBaker & Taylor$bBKTY$c119.95$d119.95$i1555811299$n0003121280$sactive
938 $aBaker and Taylor$bBTCP$n98002732
938 $aYBP Library Services$bYANK$n100125435
029 1 $aAU@$b000013666822
029 1 $aAU@$b000024713494
029 1 $aDEBBG$bBV012356655
029 1 $aGEBAY$b5846086
029 1 $aNLM$b9811831
029 1 $aNZ1$b4833578
029 1 $aYDXCP$b100125435
029 1 $aZWZ$b059738995
994 $aZ0$bP4A
948 $hHELD BY P4A - 199 OTHER HOLDINGS